Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
carcinogenicity
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
secondary source
Title:
No information
Year:
2013
Bibliographic source:
Daily Med Current Medication Information

Materials and methods

Principles of method if other than guideline:
Method not published
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Methyldopa
EC Number:
209-089-2
EC Name:
Methyldopa
Cas Number:
555-30-6
IUPAC Name:
3-hydroxy-alpha-methyl-L-tyrosine

Test animals

Species:
other: mouse and rat
Strain:
not specified
Sex:
not specified

Administration / exposure

Duration of treatment / exposure:
two years
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
up to 1800 mg/kg/day
Basis:
no data
to mice
Remarks:
Doses / Concentrations:
up to 240 mg/kg/day
Basis:
no data
to rats

Results and discussion

Applicant's summary and conclusion

Conclusions:
No evidence of a tumorigenic effect was seen when methyldopa was given for two years to mice at doses up to 1800 mg/kg/day or to rats at doses up to 240 mg/kg/day (30 and 4 times the maximum recommended human dose in mice and rats, respectively, when compared on the basis of body weight; 2.5 and 0.6 times the maximum recommended human dose in mice and rats, respectively, when compared on the basis of body surface area; calculations assume a patient weight of 50 kg).